Martin KankamDecember 16, 2016

FDA 483 - Martin Kankam - December 16, 2016

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Martin Kankam

Record Details

An FDA inspection of Martin Kankam, a clinical investigator in Overland Park, Kansas, revealed a significant issue with a clinical study. The firm failed to conduct an investigation in accordance with the investigational plan, specifically regarding incorrect dosing of subjects in a drug immunogenicity study. This indicates a serious deviation from study protocol.

Company: Martin Kankam
Inspection Date: December 16, 2016
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West II
Person: Lori Gioia (Investigator)

Open in Dashboard

ID · 84d80238-7874-4709-9fa0-112607189515